AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing

cafead

Administrator
Staff member
  • cafead   Jan 31, 2025 at 11:32: AM
via As its shares pop in Friday's session, pharmaceutical giant AbbVie Inc. (ABBV) posted a fourth quarter revenue beat and raised its long-term sales guidance for new drugs Skyrizi and Rinvoq by $4 billion.

article source